{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:55:35Z","timestamp":1792000535890,"version":"4.4.0"},"reference-count":89,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"vor","delay-in-days":295,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.csbj.2019.10.004","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T02:52:09Z","timestamp":1573095129000},"page":"1348-1359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":146,"title":["Applications and analysis of targeted genomic sequencing in cancer studies"],"prefix":"10.34133","volume":"17","author":[{"given":"Findlay","family":"Bewicke-Copley","sequence":"first","affiliation":[{"name":"Centre for Cancer Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Arjun Kumar","sequence":"additional","affiliation":[{"name":"Centre for Cancer Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK"},{"name":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Palladino","sequence":"additional","affiliation":[{"name":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koorosh","family":"Korfi","sequence":"additional","affiliation":[{"name":"Centre for Cancer Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[{"name":"Centre for Cancer Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicines3020014"},{"key":"e_1_3_3_3_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-9-222","article-title":"Genomic sequencing in clinical trials","volume":"9","author":"Mestan K.K.","year":"2011","unstructured":"Mestan K.K., Ilkhanoff L., Mouli S. and Lin S.: Genomic sequencing in clinical trials. J Transl Med 2011; 9: 1.","journal-title":"J Transl Med"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-017-4487-y"},{"key":"e_1_3_3_5_2","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.8391","article-title":"Use of dedicated gene panel sequencing using next generation sequencing to improve the personalized care of lung cancer","volume":"7","author":"Kaderbhai C.G.","year":"2016","unstructured":"Kaderbhai C.G., Boidot R., Beltjens F., Chevrier S., Arnould L., Favier L. et al: Use of dedicated gene panel sequencing using next generation sequencing to improve the personalized care of lung cancer. e20523\u2013e20523 Oncotarget 2016; 7.","journal-title":"Oncotarget"},{"key":"e_1_3_3_6_2","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1158\/1078-0432.CCR-12-1627","article-title":"Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative apostolia-maria","volume":"18","author":"Tsimberidou A.","year":"2012","unstructured":"Tsimberidou A., Iskander N.G., Hong D.S., Wheler J.J., Falchook G.S., Fu S. et al: Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative apostolia-maria. Clin Cancer Res 2012; 18: 6373.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_3_7_2","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR Project GENIE: powering precision medicine through an international consortium","volume":"7","author":"The AARC Project GENIE Consortium, Abstract","year":"2017","unstructured":"The AARC Project GENIE Consortium, Abstract : AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discov 2017; 7: 818.","journal-title":"Cancer Discov"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0657"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.06.024"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt173"},{"key":"e_1_3_3_11_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035309","article-title":"Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials","volume":"7","author":"Lovly C.M.","year":"2012","unstructured":"Lovly C.M., Dahlman K.B., Fohn L.E., Su Z., Dias-Santagata D., Hicks D.J. et al: Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials. PLoS ONE 2012; 7.","journal-title":"PLoS ONE"},{"key":"e_1_3_3_12_2","article-title":"Genome-wide detection of structural variants and indels by local assembly","volume":"105080","author":"Wala J.","year":"2017","unstructured":"Wala J., Bandopadhayay P., Greenwald N., O\u2019Rourke R., Sharpe T., Stewart C. et al: Genome-wide detection of structural variants and indels by local assembly. BioRxiv 2017; 105080.","journal-title":"BioRxiv"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040938"},{"key":"e_1_3_3_14_2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/JTO.0b013e318290868f","article-title":"Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors guideline from the college of American pathologists","volume":"8","author":"Lindeman N.I.","year":"2013","unstructured":"Lindeman N.I., Cagle P.T., Beasley M.B., Chitale D.A., Dacic S., Giaccone G. et al: Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors guideline from the college of American pathologists. Int J Thorac Oncol 2013; 8: 823.","journal-title":"Int J Thorac Oncol"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3886"},{"key":"e_1_3_3_16_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01470-y","article-title":"Prevalence and detection of low-allele-fraction variants in clinical cancer samples","volume":"8","author":"Shin H.","year":"2017","unstructured":"Shin H., Choi Y., Yun J.W., Kim N.K.D., Kim S., Jeon H.J. et al: Prevalence and detection of low-allele-fraction variants in clinical cancer samples. Nat Commun 2017; 8: 1.","journal-title":"Nat Commun"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2015-05-647172","article-title":"Disease evolution and outcomes in familial AML with germline CEBPA mutations","volume":"126","author":"Tawana K.","year":"2015","unstructured":"Tawana K., Wang J., Renneville A., Csaba B., Van Delft FW, Treleaven J. et al: Disease evolution and outcomes in familial AML with germline CEBPA mutations. Blood 2015; 126: 1214.","journal-title":"Blood"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00169-2"},{"key":"e_1_3_3_19_2","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1038\/s41598-019-41098-0","article-title":"Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator","volume":"9","author":"Oh B.Y.","year":"2019","unstructured":"Oh B.Y., Shin H.-T., Yun J.W., Kim K.-T., Kim J., Bae J.S. et al: Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator. Sci Rep 2019; 9: 4542.","journal-title":"Sci Rep"},{"key":"e_1_3_3_20_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/jmedgenet-2015-103452","article-title":"Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families","volume":"53","author":"Li J.","year":"2016","unstructured":"Li J., Meeks H., Feng B.J., Healey S., Thorne H., Makunin I. et al: Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families. J Med Genet 2016; 53: 34.","journal-title":"J Med Genet"},{"key":"e_1_3_3_21_2","article-title":"Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes","author":"Xu F.","year":"2015","unstructured":"Xu F., Wu L.Y., Chang C.K., He Q., Zhang Z., Liu L. et al: Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes. Nat Commun 2015;6.; .","journal-title":"Nat Commun"},{"key":"e_1_3_3_22_2","doi-asserted-by":"crossref","first-page":"82475","DOI":"10.18632\/oncotarget.19628","article-title":"Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing","volume":"8","author":"Wang L.","year":"2017","unstructured":"Wang L., Jing Y., Yu L., Li Y.Y., Lv N., Bo J. et al: Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing. Oncotarget 2017; 8: 82475.","journal-title":"Oncotarget"},{"key":"e_1_3_3_23_2","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","article-title":"Genetics and prognostication in splenic marginal zone lymphoma: Revelations from deep sequencing","volume":"21","author":"Parry M.","year":"2015","unstructured":"Parry M., Rose-Zerilli M.J.J., Ljungstr\u00f6m V., Gibson J., Wang J., Walewska R. et al: Genetics and prognostication in splenic marginal zone lymphoma: Revelations from deep sequencing. Clin Cancer Res 2015; 21: 4174.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_3_24_2","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41467-019-08576-5","article-title":"Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer","volume":"10","author":"Wu S.","year":"2019","unstructured":"Wu S., Ou T., Xing N., Lu J., Wan S., Wang C. et al: Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer. Nat Commun 2019; 10: 720.","journal-title":"Nat Commun"},{"key":"e_1_3_3_25_2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/humu.22825","article-title":"Evaluation of hybridization capture versus amplicon-based methods for whole-exome sequencing","volume":"36","author":"Samorodnitsky E.","year":"2015","unstructured":"Samorodnitsky E., Jewell B.M., Hagopian R., Miya J., Wing M.R., Lyon E. et al: Evaluation of hybridization capture versus amplicon-based methods for whole-exome sequencing. Hum Mutat 2015; 36: 903.","journal-title":"Hum Mutat"},{"key":"e_1_3_3_26_2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/bfgp\/elr033","article-title":"Targeted enrichment of genomic DNA regions for next-generation sequencing","volume":"10","author":"Mertes F.","year":"2011","unstructured":"Mertes F., ElSharawy A., Sauer S., van Helvoort J.M.L.M., van der Zaag P.J., Franke A. et al: Targeted enrichment of genomic DNA regions for next-generation sequencing. Brief Funct Genomics 2011; 10: 374.","journal-title":"Brief Funct Genomics"},{"key":"e_1_3_3_27_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jmoldx.2017.11.010","article-title":"Assessment of capture and amplicon-based approaches for the development of a targeted next-generation sequencing pipeline to personalize lymphoma management","volume":"20","author":"Hung S.S.","year":"2018","unstructured":"Hung S.S., Meissner B., Chavez E.A., Ben-Neriah S., Ennishi D., Jones M.R. et al: Assessment of capture and amplicon-based approaches for the development of a targeted next-generation sequencing pipeline to personalize lymphoma management. J Mol Diagnostics 2018; 20: 203.","journal-title":"J Mol Diagnostics"},{"key":"e_1_3_3_28_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0181062","article-title":"Amplification of overlapping DNA amplicons in a single-tube multiplex PCR for targeted next-generation sequencing of BRCA1 and BRCA2","volume":"12","author":"Schenk D.","year":"2017","unstructured":"Schenk D., Song G., Ke Y. and Wang Z.: Amplification of overlapping DNA amplicons in a single-tube multiplex PCR for targeted next-generation sequencing of BRCA1 and BRCA2. PLoS ONE 2017; 12: 1.","journal-title":"PLoS ONE"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4333"},{"key":"e_1_3_3_30_2","article-title":"Targeted next-generation sequencing at copy-number breakpoints for personalized analysis of rearranged ends in solid tumors","author":"Kim H.K.","year":"2014","unstructured":"Kim H.K., Park W.C., Lee K.M., Hwang H.L., Park S.Y., Sorn S. et al: Targeted next-generation sequencing at copy-number breakpoints for personalized analysis of rearranged ends in solid tumors. PLoS ONE 2014;9.; .","journal-title":"PLoS ONE"},{"key":"e_1_3_3_31_2","first-page":"8","article-title":"Spectrum and functional validation of PSMB5 mutations in multiple myeloma","author":"Barrio S.","year":"2018","unstructured":"Barrio S., St\u00fchmer T., Da-Vi\u00e1 M., Barrio-Garcia C., Lehners N., Besse A. et al: Spectrum and functional validation of PSMB5 mutations in multiple myeloma. Leukemia 2018; : 8.","journal-title":"Leukemia"},{"key":"e_1_3_3_32_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-018-0062-y","article-title":"A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5","volume":"8","author":"White B.S.","year":"2018","unstructured":"White B.S., Lanc I., O\u2019Neal J., Gupta H., Fulton R.S., Schmidt H. et al: A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5. Blood Cancer J 2018; 8.","journal-title":"Blood Cancer J"},{"key":"e_1_3_3_33_2","first-page":"204","article-title":"Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology","volume":"15213","author":"Steward D.L.","year":"2018","unstructured":"Steward D.L., Carty S.E., Sippel R.S., Yang S.P., Sosa J.A., Sipos J.A. et al: Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology. JAMA Oncol 2018; 15213: 204.","journal-title":"JAMA Oncol"},{"key":"e_1_3_3_34_2","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/cncr.31245","article-title":"Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules","volume":"124","author":"Nikiforova M.N.","year":"2018","unstructured":"Nikiforova M.N., Mercurio S., Wald A.I., Barbi de Moura M., Callenberg K., Santana-Santos L. et al: Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules. Cancer 2018; 124: 1682.","journal-title":"Cancer"},{"key":"e_1_3_3_35_2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1373\/clinchem.2014.231100","article-title":"Clinical actionability enhanced through deep targeted sequencing of solid tumors","volume":"61","author":"Chen K.","year":"2015","unstructured":"Chen K., Meric-Bernstam F., Zhao H., Zhang Q., Ezzeddine N., Tang L.Y. et al: Clinical actionability enhanced through deep targeted sequencing of solid tumors. Clin Chem 2015; 61: 544.","journal-title":"Clin Chem"},{"key":"e_1_3_3_36_2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/bjh.13171","article-title":"Targeted sequencing using a 47 gene multiple myeloma mutation panel (M3P) in -17p high risk disease","volume":"168","author":"Kort\u00fcm K.M.","year":"2015","unstructured":"Kort\u00fcm K.M., Langer C., Monge J., Bruins L., Egan J.B., Zhu Y.X. et al: Targeted sequencing using a 47 gene multiple myeloma mutation panel (M3P) in -17p high risk disease. Br J Haematol 2015; 168: 507.","journal-title":"Br J Haematol"},{"key":"e_1_3_3_37_2","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1210\/jc.2013-2292","article-title":"Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer","volume":"98","author":"Nikiforova M.N.","year":"2013","unstructured":"Nikiforova M.N., Wald A.I., Roy S., Durso M.B. and Nikiforov Y.E.: Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer. J Clin Endocrinol Metab 2013; 98: 1852.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw1121"},{"key":"e_1_3_3_39_2","first-page":"219","article-title":"Cancer Genome Atlas Pan-cancer analysis project","volume":"18","author":"Zhang K.","year":"2015","unstructured":"Zhang K. and Wang H.: Cancer Genome Atlas Pan-cancer analysis project. Chinese J Lung Cancer 2015; 18: 219.","journal-title":"Chinese J Lung Cancer"},{"key":"e_1_3_3_40_2","doi-asserted-by":"crossref","unstructured":"Lawrence MS Stojanov P Polak P Kryukov GV Cibulskis K Sivachenko A et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013;499:214\u20138. doi:10.1038\/nature12213.","DOI":"10.1038\/nature12213"},{"key":"e_1_3_3_41_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.09.042","article-title":"Universal patterns of selection in cancer and somatic tissues","volume":"171","author":"Martincorena I.","year":"2017","unstructured":"Martincorena I., Raine K.M., Gerstung M., Dawson K.J., Haase K., Van Loo P. et al: Universal patterns of selection in cancer and somatic tissues. Cell 2017; 171: e21.","journal-title":"Cell"},{"key":"e_1_3_3_42_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gks743","article-title":"Functional impact bias reveals cancer drivers","volume":"40","author":"Gonzalez-Perez A.","year":"2012","unstructured":"Gonzalez-Perez A. and Lopez-Bigas N.: Functional impact bias reveals cancer drivers. Nucleic Acids Res 2012; 40: 1.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3473"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2856"},{"key":"e_1_3_3_45_2","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/s41375-018-0043-y","article-title":"Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma","volume":"32","author":"Araf S.","year":"2018","unstructured":"Araf S., Wang J., Korfi K., Pangault C., Kotsiou E., Rio-Machin A. et al: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma. Leukemia 2018; 32: 1258.","journal-title":"Leukemia"},{"key":"e_1_3_3_46_2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1507471","article-title":"Assessment of minimal residual disease in standard-risk AML","volume":"374","author":"Ivey A.","year":"2016","unstructured":"Ivey A., Grech A., Vyas P., Patel Y., Freeman S.D., Griffiths M. et al: Assessment of minimal residual disease in standard-risk AML. N Engl J Med 2016; 374: 422.","journal-title":"N Engl J Med"},{"key":"e_1_3_3_47_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms8686","article-title":"Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients","volume":"6","author":"Sausen M.","year":"2015","unstructured":"Sausen M., Phallen J., Adleff V., Jones S., Leary R.J., Barrett M.T. et al: Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. Nat Commun 2015; 6: 1.","journal-title":"Nat Commun"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa6806"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature11143"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.1414"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0317-6"},{"key":"e_1_3_3_52_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads kenkyuhi hojokin gan rinsho kenkyu jigyo","volume":"17","author":"Martin M.","year":"2013","unstructured":"Martin M.: Cutadapt removes adapter sequences from high-throughput sequencing reads kenkyuhi hojokin gan rinsho kenkyu jigyo. EMBnet J 2013; 17: 10.","journal-title":"EMBnet J"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq033"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp698"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.1923"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp352"},{"key":"e_1_3_3_57_2","first-page":"2078","article-title":"The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data Aaron","volume":"25","author":"McKenna A.","year":"2010","unstructured":"McKenna A., Hanna M., Banks E., Sivachenko A., Cibulskis K., Kernytsky A. et al: The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data Aaron. Genome Res 2010; 25: 2078.","journal-title":"Genome Res"},{"key":"e_1_3_3_58_2","article-title":"Strelka2: fast and accurate calling of germline and somatic variants","author":"Kim S.","year":"2018","unstructured":"Kim S., Scheffler K., Halpern A.L., Bekritsky M.A., Noh E., K\u00e4llberg M. et al: Strelka2: fast and accurate calling of germline and somatic variants. Nat Methods 2018; .","journal-title":"Nat Methods"},{"key":"e_1_3_3_59_2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Wilson R.K.","year":"2012","unstructured":"Wilson R.K., Mardis E.R., McLellan M.D., Koboldt D.C., Shen D., Zhang Q. et al: VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 2012; 22: 568.","journal-title":"Genome Res"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp394"},{"key":"e_1_3_3_61_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang K.","year":"2010","unstructured":"Wang K., Li M. and Hakonarson H.: ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010; 38: 1.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.4161\/fly.19695"},{"key":"e_1_3_3_63_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren W.","year":"2016","unstructured":"McLaren W., Gil L., Hunt S.E., Riat H.S., Ritchie G.R.S., Thormann A. et al: The ensembl variant effect predictor. Genome Biol 2016; 17: 1.","journal-title":"Genome Biol"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/782465"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu356"},{"key":"e_1_3_3_66_2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/bioinformatics\/bts053","article-title":"JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal\/tumour paired next-generation sequencing data","volume":"28","author":"Roth A.","year":"2012","unstructured":"Roth A., Ding J., Morin R., Crisan A., Ha G., Giuliany R. et al: JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal\/tumour paired next-generation sequencing data. Bioinformatics 2012; 28: 907.","journal-title":"Bioinformatics"},{"key":"e_1_3_3_67_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-018-2440-7","article-title":"Comparing the performance of selected variant callers using synthetic data and genome segmentation","volume":"19","author":"Bian X.","year":"2018","unstructured":"Bian X., Zhu B., Wang M., Hu Y., Chen Q., Nguyen C. et al: Comparing the performance of selected variant callers using synthetic data and genome segmentation. BMC Bioinf 2018; 19: 1.","journal-title":"BMC Bioinf"},{"key":"e_1_3_3_68_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0151664","article-title":"Evaluation of nine somatic variant callers for detection of somatic mutations in exome and targeted deep sequencing data","volume":"11","author":"Kr\u00f8ig\u00e5rd A.B.","year":"2016","unstructured":"Kr\u00f8ig\u00e5rd A.B., Thomassen M., L\u00e6nkholm A.V., Kruse T.A. and Larsen M.J.: Evaluation of nine somatic variant callers for detection of somatic mutations in exome and targeted deep sequencing data. PLoS ONE 2016; 11: 1.","journal-title":"PLoS ONE"},{"key":"e_1_3_3_69_2","first-page":"1","article-title":"Intersect-then-combine approach: improving the performance of somatic variant calling in whole exome sequencing data using multiple aligners and callers","volume":"9","author":"Chin S.-F.","year":"2017","unstructured":"Chin S.-F., Bruna A., Callari M., De Mattos-Arruda L., Caldas C., Sammut S.-J. et al: Intersect-then-combine approach: improving the performance of somatic variant calling in whole exome sequencing data using multiple aligners and callers. Genome Med 2017; 9: 1.","journal-title":"Genome Med"},{"key":"e_1_3_3_70_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07406-4","article-title":"High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer","volume":"9","author":"Echeverria G.V.","year":"2018","unstructured":"Echeverria G.V., Powell E., Seth S., Ge Z., Carugo A., Bristow C. et al: High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer. Nat Commun 2018; 9.","journal-title":"Nat Commun"},{"key":"e_1_3_3_71_2","first-page":"1","article-title":"Evaluating somatic tumor mutation detection without matched normal samples","volume":"11","author":"Teer J.K.","year":"2017","unstructured":"Teer J.K., Zhang Y., Chen L., Welsh E.A., Cress W.D., Eschrich S.A. et al: Evaluating somatic tumor mutation detection without matched normal samples. Hum Genomics 2017; 11: 1.","journal-title":"Hum Genomics"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu067"},{"key":"e_1_3_3_73_2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5808\/GI.2015.13.2.31","article-title":"Effect of next-generation exome sequencing depth for discovery of diagnostic variants","volume":"13","author":"Kim K.","year":"2015","unstructured":"Kim K., Seong M.-W., Chung W.-H., Park S.S., Leem S., Park W. et al: Effect of next-generation exome sequencing depth for discovery of diagnostic variants. Genomics Inform 2015; 13: 31.","journal-title":"Genomics Inform"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature07517"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbq016"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.123638.111"},{"key":"e_1_3_3_77_2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/0471250953.bi1504s44","article-title":"Using VarScan 2 for germline variant calling and somatic mutation detection","volume":"44","author":"Koboldt D.C.","year":"2013","unstructured":"Koboldt D.C., Larson D.E. and Wilson R.K.: Using VarScan 2 for germline variant calling and somatic mutation detection. Curr Protoc Bioinforma 2013; 44: 233.","journal-title":"Curr Protoc Bioinforma"},{"key":"e_1_3_3_78_2","first-page":"1","article-title":"Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas","volume":"15","author":"Jiang Y.","year":"2014","unstructured":"Jiang Y., Redmond D., Nie K., Eng K.W., Clozel T., Martin P. et al: Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas. Genome Biol 2014; 15: 1.","journal-title":"Genome Biol"},{"key":"e_1_3_3_79_2","first-page":"1","article-title":"Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing","volume":"7","author":"Wong S.Q.","year":"2014","unstructured":"Wong S.Q., Li J., Tan A.Y.C., Vedururu R., Pang J.M.B., Do H. et al: Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing. BMC Med Genomics 2014; 7: 1.","journal-title":"BMC Med Genomics"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22771"},{"key":"e_1_3_3_81_2","article-title":"Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes","volume":"531210","author":"Karczewski K.J.","year":"2019","unstructured":"Karczewski K.J., Francioli L.C., Tiao G., Cummings B.B., Alf\u00f6ldi J., Wang Q. et al: Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. BioRxiv 2019; 531210.","journal-title":"BioRxiv"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature19057"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2890"},{"key":"e_1_3_3_84_2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jmoldx.2017.01.011","article-title":"Guidelines for validation of next-generation sequencing-based oncology panels: a joint consensus recommendation of the association for molecular pathology and college of American pathologists","volume":"19","author":"Jennings L.J.","year":"2017","unstructured":"Jennings L.J., Arcila M.E., Corless C., Kamel-Reid S., Lubin I.M., Pfeifer J. et al: Guidelines for validation of next-generation sequencing-based oncology panels: a joint consensus recommendation of the association for molecular pathology and college of American pathologists. J Mol Diagnostics 2017; 19: 341.","journal-title":"J Mol Diagnostics"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrg.2017.117"},{"key":"e_1_3_3_86_2","doi-asserted-by":"crossref","unstructured":"Deng S Lira M Huang S Wang K Valdez C Kinong J et al. TNER\u202f: a novel background error suppression method for mutation detection in circulating tumor DNA 2017:1\u201312. doi:10.1101\/214379.","DOI":"10.1101\/214379"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3520"},{"key":"e_1_3_3_88_2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/bioinformatics\/bts146","article-title":"CONTRA: Copy number analysis for targeted resequencing","volume":"28","author":"Li J.","year":"2012","unstructured":"Li J., Lupat R., Amarasinghe K.C., Thompson E.R., Doyle M.A., Ryland G.L. et al: CONTRA: Copy number analysis for targeted resequencing. Bioinformatics 2012; 28: 1307.","journal-title":"Bioinformatics"},{"key":"e_1_3_3_89_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-017-1566-3","article-title":"SeqCNV: A novel method for identification of copy number variations in targeted next-generation sequencing data","volume":"18","author":"Chen Y.","year":"2017","unstructured":"Chen Y., Zhao L., Wang Y., Cao M., Gelowani V., Xu M. et al: SeqCNV: A novel method for identification of copy number variations in targeted next-generation sequencing data. BMC Bioinf 2017; 18: 1.","journal-title":"BMC Bioinf"},{"key":"e_1_3_3_90_2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nmeth.3407","article-title":"Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection","volume":"12","author":"Ewing A.D.","year":"2016","unstructured":"Ewing A.D., Houlahan K.E., Hu Y., Ellrott K., Caloian C., Yamaguchi T.N. et al: Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection. Nat Methods 2016; 12: 623.","journal-title":"Nat Methods"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037019301473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037019301473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2019.10.004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T21:04:55Z","timestamp":1778015095000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2019.10.004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":89,"alternative-id":["10.1016\/j.csbj.2019.10.004"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2019.10.004","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applications and analysis of targeted genomic sequencing in cancer studies","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2019.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}